Paid Clinical Trials in Hamilton, NJ
As of June 2026, 28 paid clinical trials are recruiting in Hamilton, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hamilton offers studies at sites including The Cancer Institute of New Jersey Hamilton for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Chronic Obstructive Pulmonary Disease, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hamilton
Trials by drug in Hamilton
Filter results
28 clinical trials
↓ Download CSVA Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult Males
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
ATATcH Alternating Treatment Plans for Advanced Cancer
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
About research studies in Hamilton
Hamilton has approximately 28 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Hamilton
Researchers run research studies in Hamilton, NJ at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| The Cancer Institute of New Jersey Hamilton | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Anatomic Stage III Breast Cancer AJCC v8 | 9 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton | Breast Neoplasms, Cardiac Toxicity, Colorectal Neoplasms | 3 |
| Circuit Clinical/Mercer Allergy and Pulmonary Associates | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Perennial Allergic Rhinitis (PAR) | 2 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Gastro-Intestinal Cancer, Metastases, Neoplasm, Neoplasm Metastases | 2 |
| Trialfinity Clinical Research Center | Chronic Obstructive Pulmonary Disease, Urinary Incontinence | 2 |
| Bioluminux Clinical Research | Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases | 1 |
| Bioluminux Clinical Research - Hamilton, New Jersey | Chronic Obstructive Pulmonary Disease | 1 |
| Bioluminux Clinical Research New Jersey | Proteinuric Kidney Disease | 1 |
| Cancer Institute of New Jersey at Hamilton | Head and Neck Cancer, Lung Cancer | 1 |
| Circuit Clinical Mercer Algy Pulm | Chronic Spontaneous Urticaria (CSU) | 1 |
| Clinical Reseach Philadelphia Pennington | Cardiovascular Disease | 1 |
| Hamilton Surgery Center | Lumbar Spinal Stenosis | 1 |
| RWJ Barnabas Health - Robert Wood Johnson University Hospital, Hamilton | HER2-Negative Breast Cancer, Hormone Receptor-Positive Breast Cancer | 1 |
| Robert Wood Johnson University Hospital, Hamilton | Metastatic Colon Carcinoma, Stage IV Colon Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8 | 1 |
| Vanda Investigational Site | Nausea and Vomiting, Obesity | 1 |
Active & Upcoming Studies in Hamilton (2026)
Recruiting trials in Hamilton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (15 active studies)
- Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer · Phase 2 · Rutgers, The State University of New Jersey
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (2 active studies)
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) · Phase 2 · Pfizer
- A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use · Phase 3 · Vanda Pharmaceuticals
Cardiovascular (1 active study)
- Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted · Phase 2 · Rutgers, The State University of New Jersey
Common conditions studied in Hamilton
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Breast Cancer (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Chronic Obstructive Pulmonary Disease (2 active studies). COPD research evaluates biologic therapies, triple-inhaler combinations, and new anti-inflammatory agents to reduce exacerbations.
- Obesity (2 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Anatomic Stage III Breast Cancer AJCC v8 (1 active study). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage IIIA Breast Cancer AJCC v8 (1 active study). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Hamilton
- Rutgers, The State University of New Jersey
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Eli Lilly and Company
- National Cancer Institute (NCI)
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Hamilton. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Hamilton
Hipa.ai aggregates every recruiting study in Hamilton from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Hamilton?
There are approximately 28 recruiting clinical trials in Hamilton, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hamilton pay participants?
Most recruiting trials in Hamilton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hamilton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hamilton?
The most common conditions under active study in Hamilton include Anatomic Stage II Breast Cancer AJCC v8 (2), Breast Cancer (2), Chronic Obstructive Pulmonary Disease (2), Obesity (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hamilton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hamilton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hamilton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hamilton?
Recruiting research sites in Hamilton include The Cancer Institute of New Jersey Hamilton, RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, Circuit Clinical/Mercer Allergy and Pulmonary Associates, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hamilton right now?
The largest active categories in Hamilton are Cancer & tumors (15), Diabetes & metabolic (2), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.